Relating to: cost-sharing cap on epinephrine delivery systems under health insurance policies and plans. (FE)

SB 764 sets a $60 annual cap on out-of-pocket costs for two doses of epinephrine delivery systems (like EpiPens) under health insurance policies and self-insured plans. It directly affects people with severe allergies who rely on these devices and their insurers. The bill requires coverage for medically necessary epinephrine delivery systems with cost-sharing limited to $60 for two doses, regardless of device type, while allowing plans to charge less or nothing. This applies to disability insurance policies, state/local government health plans, and all health insurance plans covering these devices. The law takes effect four months after publication, with transitional rules for existing policies and collective bargaining agreements.